| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/02/2005 | CN1575302A Human tissue factor antibodies |
| 02/02/2005 | CN1572876A Glyt1 conditional knock-out mice |
| 02/02/2005 | CN1572874A Recombination high molecular form mannose binding lectin (MBL), preparing method and application thereof |
| 02/02/2005 | CN1572870A Method for storing human ovocyte |
| 02/02/2005 | CN1572869A Media and methods for promoting maturation of conifer somatic embryos |
| 02/02/2005 | CN1572801A Double functional fusion protein possessing antineoplastic functions, method for making same and use thereof |
| 02/02/2005 | CN1572800A Specific antibody of tumor-associated antigen SM5-1 and use thereof |
| 02/02/2005 | CN1572322A Attenuated live neospora vaccine |
| 02/02/2005 | CN1187453C Cell lines for propagation of mutated herpes viruses |
| 02/02/2005 | CN1187452C Promotor |
| 02/02/2005 | CN1187450C Method for producing transgenic non-human mammal |
| 02/02/2005 | CN1187447C MPL ligand analogs |
| 02/02/2005 | CN1187442C Method for transferring antigens to dendritic cells |
| 02/02/2005 | CN1187441C Medium for culturing animal cells and process for producing protein by using same |
| 02/02/2005 | CN1187374C Humanized antibody specific for human 4-1BB and pharmaceutical compsn comprising same |
| 02/02/2005 | CN1187086C Hybrid with interferon alpha and immunoglobulin Fc linked through non-immunogenic peptide |
| 02/01/2005 | US6849782 Arabidopsis antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants |
| 02/01/2005 | US6849724 Method for transforming plant, the resultant plant and gene thereof |
| 02/01/2005 | US6849720 Monoclonal antibodies to the human LDL receptor, their production and use |
| 02/01/2005 | US6849718 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 02/01/2005 | US6849612 Oligonucleotide modulation of cell adhesion |
| 02/01/2005 | US6849606 Method of inducing or enhancing chondrogenesis with extracellular matrix containing GDF-5 |
| 02/01/2005 | US6849602 Compositions for alleviating neuropathic pain with prosaposin receptor agonists |
| 02/01/2005 | US6849453 Method and composition for clonal propagation of Pandanus amaryllifolius |
| 02/01/2005 | US6849452 Bringing an enriched population of resting NK cells into contact with mature or triggered dendritic cells in vitro or ex vivo, under conditions allowing activation of such resting NK cells by mature or triggered cells |
| 02/01/2005 | US6849451 Hybrid cells |
| 02/01/2005 | US6849446 Genetic engineering |
| 02/01/2005 | US6849436 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria |
| 02/01/2005 | US6849427 Dermatophagoides pteronyssinus proteins |
| 02/01/2005 | US6849423 Separating preferential particles from solution; obtain sample, detect particle in sample, expose sample to acoustic vibration, recover particles from fluid |
| 02/01/2005 | US6849421 Nucleotide sequences coding enzymatic polypeptide for the use in the treatment of nervous system disorders |
| 02/01/2005 | US6849420 Isolated autophosphorylating polypeptide, possessing PI3 kinase (phosphoinositide-3 kinase) activity; use drug screening for regulators of cell motility, such as antimetastasis agents |
| 02/01/2005 | US6849413 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders |
| 02/01/2005 | US6849405 Incorporated into expression vectors to enhance recombinant protein production |
| 02/01/2005 | US6849394 Compositions comprising reproductive cell media and methods for using such compositions |
| 02/01/2005 | US6849266 Lyme disease; enclosure aperture which applies fipronil to parasites on rodents |
| 02/01/2005 | US6849261 CD4-independent HIV envelope proteins as vaccines and therapeutics |
| 02/01/2005 | US6849255 Administering a cell that expresses at least one factor of the T-box family, such as brachyury. |
| 02/01/2005 | CA2325351C Non-stochastic generation of genetic vaccines and enzymes |
| 02/01/2005 | CA2248140C Assay and reagents for quantifying hbnp |
| 02/01/2005 | CA2094261C Polypeptide of a growth factor receptor family, application in the diagnosis and treatment of myeloproliferative diseases |
| 02/01/2005 | CA2069541C Induction of an antigen-specific t-lymphocyte response |
| 01/27/2005 | WO2005007888A1 Reporter gene assay, kit therefor and culture medium |
| 01/27/2005 | WO2005007845A2 Transgenic cells |
| 01/27/2005 | WO2005007839A1 METHOD OF PREPARING LANGERHANS CELL FROM CD14-POSITIVE CELL BEING HUMAN PERIPHERAL-BLOOD MONONUCLEAR CELL WITH USE OF NOTCH LIGAND DELTA-1, GM-CSF AND TGF-β |
| 01/27/2005 | WO2005007838A1 Cell diffrentiation inhibitor, cell culture method using the same, liquid culture medium and cultured cell line |
| 01/27/2005 | WO2005007837A1 Irradiated osteoinductive extracellular material |
| 01/27/2005 | WO2005007836A1 Regulatory t-cells containing galectins for the therapy and diagnosis of diseases |
| 01/27/2005 | WO2005007835A1 Methods of preparing a transplantable product for treatment of skin defects |
| 01/27/2005 | WO2005007829A2 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 01/27/2005 | WO2005007825A2 Modulation of aminopeptidase n expression |
| 01/27/2005 | WO2005007811A2 Injection of bone marrow-derived cells and medium for angiogenesis |
| 01/27/2005 | WO2005007808A2 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 01/27/2005 | WO2005007799A2 Methods for ex-vivo expanding stem/progenitor cells |
| 01/27/2005 | WO2005007797A2 Oligodendrocyte precursor cells and methods of obtaining and culturing the same |
| 01/27/2005 | WO2005007796A2 Improved multiwell plate |
| 01/27/2005 | WO2005007717A1 Thermosensitive polymers for therapeutic use and methods of preparation |
| 01/27/2005 | WO2005007700A1 Antibodies to cd44 vra and methods of use |
| 01/27/2005 | WO2005007674A2 Anti-human vitronectin antibody and methods for making the same |
| 01/27/2005 | WO2005007233A2 Application of electrical stimulation for functional tissue engineering in vitro and in vivo |
| 01/27/2005 | WO2005007199A1 COMPOUNDS AND METHODS FOR DOWNREGULATING THE EFFECTS OF TGF-β |
| 01/27/2005 | WO2005007176A1 Remedy for internal administration against cranial nerve diseases containing mesenchymal cells as the active ingredient |
| 01/27/2005 | WO2005007175A2 Cadherin directed molecular and cellular localization |
| 01/27/2005 | WO2005007116A2 Artificial antigen presenting cell devices |
| 01/27/2005 | WO2005007073A2 Ex vivo progenitor and stem cell expansion for use in the treatment of disease of endodermally-derived organs |
| 01/27/2005 | WO2005006947A2 Cells for use in locating and targeting tumor cells |
| 01/27/2005 | WO2005006944A2 Devices and methods for assessing spinal and implant motion and for optimizing alignment and movement |
| 01/27/2005 | WO2005006864A1 Genetic vaccines for cancer therapy |
| 01/27/2005 | WO2004093934A3 Materials and methods for augmenting and/or repairing intervertebral discs |
| 01/27/2005 | WO2004084950A3 Cell targeting methods and compositions |
| 01/27/2005 | WO2004074325A3 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
| 01/27/2005 | WO2004060053A3 Transgenic mice expressing human cd20 |
| 01/27/2005 | WO2004038002A3 Modulation of dendritic cell function and other cellular responses mediated by defensin compositions |
| 01/27/2005 | WO2003091412A3 Generation of plants with improved pathogen resistance |
| 01/27/2005 | WO2003087374A9 Derivatives of the il-2 receptor gamma chain, their production and use. |
| 01/27/2005 | WO2003062400A3 Fiber shaft modifications for efficient targeting |
| 01/27/2005 | WO2003057826A3 SOLUBLE GLcNAC PHOSPHOTRANSFERASE |
| 01/27/2005 | WO2002042417A3 Human erg2 potassium channel |
| 01/27/2005 | US20050022260 Genetically engineered avian for use as bioreactors in heterologous protein expression; animal model for disease |
| 01/27/2005 | US20050022259 Genetically engineered embryonic stem cells for use in prevention and treatment of cell proliferfative disorders; gene therapy |
| 01/27/2005 | US20050022258 Genetically determined mouse model of resistance to transplantable cancers |
| 01/27/2005 | US20050022257 Transgenic animals harboring appallele having swedish mutation |
| 01/27/2005 | US20050021089 Compositions and methods for treating cardiac dysfunction |
| 01/27/2005 | US20050020817 Nucleotide sequences coding tumor marker protein for use as tools in detection, prevention a nd treatment of cell proliferative disorders |
| 01/27/2005 | US20050020526 Oligodeoxynucleotide intervention for prevention and treatment of sepsis |
| 01/27/2005 | US20050020522 Induce mitrosis and smooth muscle proliferation; administering to cell or tissue a polynucleotide which codes endothelial growth factor |
| 01/27/2005 | US20050020519 Increase concentration of peptide; controlling glucose uptake into cells; adjust metabolism; stimulate cell proliferation; reduce apoptosis; moderate gene expression' |
| 01/27/2005 | US20050019929 Deleted adenovirus vectors and methods of making and administering the same |
| 01/27/2005 | US20050019927 DECREASING GENE EXPRESSION IN A MAMMALIAN SUBJECT IN VIVO VIA AAV-MEDIATED RNAi EXPRESSION CASSETTE TRANSFER |
| 01/27/2005 | US20050019920 Culturing plant explant in nutrient broth; propagation of medicinal plants |
| 01/27/2005 | US20050019917 Methods and solutions for storing donor organs |
| 01/27/2005 | US20050019914 Perfusion process for producing erythropoietin |
| 01/27/2005 | US20050019913 Methods for cultivating cells and propagating viruses |
| 01/27/2005 | US20050019912 Method od cell culture |
| 01/27/2005 | US20050019911 Used to augment bone marrow transplantation; drug delivery, gene therapy |
| 01/27/2005 | US20050019910 Human cell culture medium and culture method |
| 01/27/2005 | US20050019909 Modified retinal pigment epithelial cells for cell transplantation |
| 01/27/2005 | US20050019908 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 01/27/2005 | US20050019907 Cell culture derived from trisomic embryos for use as model in monitoring and screeen metobilic disorders; tissue replacement, cancer therapy, drug screening and discovery |
| 01/27/2005 | US20050019906 Single media in vitro support of fertilized embryos to the implantation stage |